Selective autophagy of whole micronuclei suppresses chromosomal instability

This study reveals that cells employ a selective autophagy mechanism, termed "chromophagy," to detect and completely digest micronuclei with nuclear envelope defects, thereby preventing catastrophic chromosomal rearrangements and suppressing chromosomal instability.

The Gist

The Big Picture: The Cell's "Garbage Disposal" for Broken Nuclei

Imagine a cell as a bustling factory. Inside this factory, there is a main control room called the nucleus, which holds the blueprints (DNA) needed to run the business.

Sometimes, when the factory divides to make a new unit (cell division), things go wrong. A piece of the blueprint gets left behind, or a whole section of the control room gets squeezed out. This leftover piece forms a tiny, separate, and wobbly control room called a micronucleus.

Usually, these micronuclei are troublemakers. They are fragile, prone to bursting, and if they burst, they scatter the blueprints everywhere, causing chaos and mutations. This is a major driver of cancer.

The Discovery:
This paper reveals that cells have a secret, specialized "garbage disposal" system specifically designed to eat these broken micronuclei before they can cause damage. The authors call this process "Chromophagy" (literally: chromosome-eating).

---

The Story in Three Acts

Act 1: The "Broken Window" Signal

Not all micronuclei are the same. Some are sturdy; others are flimsy.

• The Analogy: Imagine the main nucleus is a castle with a strong stone wall (the nuclear envelope). A micronucleus is like a tiny, hastily built shed.
• The Problem: Some of these sheds have a "broken window" (defects in the nuclear envelope). The cell can sense this weakness.
• The Trigger: When the cell detects a shed with a broken window, it doesn't try to fix it. Instead, it marks it for removal. The paper found that the "glue" holding the shed's walls together (proteins called BAF and Lamin B1) starts to fall apart. This falling apart is the "Eat Me" sign.

Act 2: The Garbage Truck Arrives (Autophagy)

Once the cell spots the broken shed, it sends in a cleanup crew.

• The Process: The cell wraps the entire tiny shed inside a bubble (an autophagosome) and delivers it to the factory's recycling center (the lysosome).
• The Result: The recycling center is acidic and full of digestive enzymes. It dissolves the entire micronucleus, including all the DNA inside it.
• The Contrast: If the cell doesn't eat the micronucleus, the shed eventually bursts (ruptures). When it bursts, it spills its contents, causing a "chromosomal explosion" (chromothripsis) that scrambles the blueprints.
  • Eating the shed = Clean removal, no mess.
  • Letting it burst = Catastrophic explosion, permanent damage.

Act 3: The Final Verdict (Chromophagy)

The researchers proved that when the cell eats the micronucleus, the DNA inside is completely destroyed.

• The Consequence: The cell loses that specific piece of the blueprint forever. It's a trade-off: the cell accepts losing a little bit of its genetic material to prevent a massive, chaotic explosion that could turn the factory into a cancerous nightmare.
• The Name: They named this process Chromophagy (Chromosome + Eating).

---

Why Does This Matter?

1. It's a Safety Valve for Cancer
Cancer often evolves because cells keep making mistakes with their chromosomes, leading to more and more mutations. Chromophagy acts like a safety valve. By removing the "bad apples" (the broken micronuclei) before they explode, the cell stops the cycle of chaos. It keeps the factory stable, even if it means losing a few blueprints.

2. It Explains a Mystery in Cancer Genomes
Scientists have long noticed that cancer cells tend to lose whole chromosomes more often than they gain them. This paper explains why: The cell's "garbage disposal" (Chromophagy) is actively eating and deleting chromosomes to stop them from causing trouble.

3. A New Therapeutic Idea
If we can understand exactly how the cell decides to eat these micronuclei, we might be able to turn this mechanism on or off.

• Turning it ON: In early cancer, we could force the cell to eat the broken parts, stabilizing the genome and stopping the cancer from evolving into something worse.
• Turning it OFF: In advanced cancer, maybe we don't want the cell to clean up the mess. If we stop the garbage disposal, the cancer cells might accumulate so much chaos that they destroy themselves.

Summary in One Sentence

Cells have discovered a way to identify and swallow broken, dangerous mini-nuclei whole before they can burst and cause genetic chaos, effectively "eating" the problem to save the cell from cancer.

Technical Summary

1. Problem Statement

Chromosomal instability (CIN) is a hallmark of cancer, driven by mitotic errors that result in the missegregation of chromosomes into micronuclei (MN). Micronuclei are prone to nuclear envelope (NE) rupture, leading to catastrophic DNA rearrangements (e.g., chromothripsis) and the propagation of genomic instability across cell generations. While cells possess mechanisms to prevent micronucleation, it remains unclear whether cells have active mechanisms to restrain the genomic consequences of micronuclei once they have formed. Specifically, the fate of micronuclei and whether selective degradation pathways exist to prevent the transmission of damaged chromosomal material were unknown.

2. Methodology

The authors employed a multidisciplinary approach combining live-cell imaging, molecular genetics, and single-cell genomics:

• Live-Cell Acidification Sensor: Developed a novel reporter (H2B-mKeima) where histone H2B is fused to the pH-sensitive fluorophore mKeima. This allows real-time tracking of chromatin acidification, a hallmark of lysosomal degradation, within micronuclei.
• Multimodal Live Imaging: Used multi-channel imaging to track:
  • Chromatin (H2B-mKeima).
  • Autophagosomes (LC3B-GFP).
  • Lysosomes (SiR-Lysosome).
  • Nuclear envelope integrity (HaloTag-NLS) and cytosolic DNA exposure (BAF-GFP).
  • Holotomography: Label-free 3D imaging to visualize membrane dynamics around micronuclei.
• Genetic and Pharmacological Perturbation:
  • Knockout/Knockdown: CRISPR/Cas9 generation of ATG7 KO cell lines and siRNA depletion of autophagy factors (ATG16L1, LC3B, GABARAP).
  • Pharmacology: Use of autophagy inducers (Torin1, AZD8055, starvation) and inhibitors (PIK-III, Chloroquine, Bafilomycin A1).
  • Specific Inhibitors: Targeted VRK1 kinase (VRK-IN-1) and MKLP2 (Paprotrain) to probe chromatin-NE tethering mechanisms.
• Single-Cell Genomics (Strand-seq):
  • Used DACT-1 photoactivation to isolate sister cell pairs with known micronucleus fates (acidified vs. non-acidified).
  • Performed Strand-seq (template strand sequencing) to reconstruct reciprocal de novo chromosomal alterations (CAs) and determine Watson (W) vs. Crick (C) template strand ratios. This allowed the detection of non-reciprocal chromosome loss.
• Correlative Light and Electron Microscopy (CLEM): Combined live imaging with TEM to visualize the ultrastructure of micronuclei targeted by autophagy.

3. Key Contributions

• Discovery of "Chromophagy": The authors define a new selective autophagy pathway termed chromophagy (chromosome-autophagy), where entire micronuclei are captured by autophagosomes and degraded in lysosomes.
• Mechanism of Selectivity: Identified that chromophagy selectively targets micronuclei with defective nuclear envelope assembly (specifically those derived from lagging chromosomes), characterized by the progressive dissociation of chromatin-NE tethering proteins (BAF and Lamin B1).
• Fate Dichotomy: Established that micronucleus rupture and autophagy are mutually exclusive, competing fates. Rupture leads to DNA damage and rearrangement, while autophagy leads to complete degradation of the chromosomal content.
• Genomic Consequence: Demonstrated that chromophagy results in the non-reciprocal loss of whole chromosomes or chromosome arms, effectively "cleaning" the genome of missegregated material but at the cost of aneuploidy.

4. Key Results

A. Identification of Whole-Micronucleus Autophagy

• Approximately 10–30% of micronuclei in human cells (U2OS, HeLa, RPE-1) undergo sudden acidification, indicating lysosomal fusion.
• This process involves the stepwise capture of the entire micronucleus within LC3B-positive autophagosomes, followed by lysosomal fusion.
• Acidification is dependent on core autophagy machinery (ATG7, LC3B, GABARAP) and is blocked by autophagy inhibitors but enhanced by inducers.

B. Rupture vs. Autophagy: Distinct Fates

• Mutual Exclusivity: Micronuclei that rupture (indicated by BAF recruitment and loss of NLS signal) almost never undergo acidification (<2%). Conversely, acidified micronuclei maintain nuclear compartmentalization.
• Competition: Enhancing autophagy (via Torin1) reduces rupture rates, while inhibiting autophagy (via PIK-III) increases rupture rates, suggesting a competitive relationship between these two fates.
• DNA Integrity: Post-rupture micronuclei show extensive DNA damage ($\gamma$H2AX), whereas post-acidification micronuclei show no detectable DNA damage prior to degradation.

C. Mechanistic Basis: Chromatin-NE Untethering

• Selectivity: Chromophagy selectively targets micronuclei derived from lagging chromosomes (which have defective NE assembly) rather than misaligned chromosomes.
• The Trigger: Acidification-fated micronuclei exhibit a progressive dissociation of BAF and Lamin B1 from the nuclear envelope. This loss of tethering increases membrane fluidity and deformation.
• Regulation:
  • VRK1 Kinase: Inhibition of VRK1 (which phosphorylates BAF) stabilizes BAF-NE binding and reduces acidification rates.
  • Lamin B1: Overexpression of Lamin B1 strengthens tethering and suppresses chromophagy.
  • Mitotic Origin: Defects seeded at mitotic exit (rescued by Paprotrain) are the root cause of the tethering failure.

D. Genomic Consequences: Chromophagy

• Degradation: Live imaging shows rapid loss of DNA signal in acidified micronuclei, confirmed by TUNEL and EdU assays.
• Strand-seq Analysis:
  • In non-acidified sister pairs, chromosome losses are reciprocal (one sister gains, the other loses), consistent with standard missegregation.
  • In acidified sister pairs, there is a significant enrichment of non-reciprocal chromosome loss (W:C ratio skewing to 1:2 or 2:1).
  • This confirms that the chromosomal content of the micronucleus is completely digested and eliminated from the genome.
• Intergenerational Arrest: Chromophagy prevents the transmission of micronuclei-derived fragments to daughter cells. Cells undergoing chromophagy produce daughters with background levels of micronuclei and DNA damage, whereas cells with non-degraded micronuclei pass on fragmented DNA (MN bodies) and high $\gamma$H2AX levels.

5. Significance

• Suppression of Chromothripsis: By eliminating micronuclei before they rupture, chromophagy prevents the catastrophic DNA rearrangements (chromothripsis) that drive cancer evolution.
• Tumor Suppression vs. Maintenance:
  • In normal cells (p53-proficient), chromophagy acts as a genome surveillance mechanism, suppressing CIN and potentially tumor initiation.
  • In established cancer cells, it may act as a "buffer," allowing cells to survive by removing highly unstable chromosomes, thereby maintaining a level of CIN that supports tumor growth without causing cell death.
• Explaining Mutational Bias: Chromophagy provides a mechanistic explanation for the observed predominance of chromosome losses over gains in cancer genomes. The selective degradation of micronuclei leads to a net loss of genetic material.
• Therapeutic Potential: Modulating chromophagy could be a novel therapeutic strategy. Activating chromophagy might stabilize tumor genomes and prevent the emergence of resistant subclones driven by complex rearrangements, while inhibiting it in specific contexts could push highly unstable cancer cells toward lethal genomic catastrophe.

In summary, the paper identifies chromophagy as a critical cellular defense mechanism that selectively degrades defective micronuclei via autophagy, thereby arresting the intergenerational transmission of genomic instability and shaping the landscape of chromosomal alterations in cancer.